Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples